EMPLICITI
NDC 0003-2291, elotuzumab, injection, powder, lyophilized, for solution, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-2291
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761035
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ELOTUZUMAB300 mg/1
Pharmacologic classes
Antibodies, Monoclonal [CS]; SLAMF7-directed Antibody Interactions [MoA]; SLAMF7-directed Immunostimulatory Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-2291-11 | 00003229111 | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2291-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/80686b7e-f6f4-4154-b5c0-c846425e2d91Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0003-2291
Use it
Look up 0003-2291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-2291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.